Filing Details
- Accession Number:
- 0001384101-17-000064
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-20 16:46:15
- Reporting Period:
- 2017-10-18
- Accepted Time:
- 2017-10-20 16:46:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1588970 | H Bonnie Anderson | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-18 | 6,000 | $2.36 | 16,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-18 | 6,000 | $9.09 | 10,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-10-20 | 10,000 | $2.68 | 20,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-20 | 10,000 | $9.60 | 10,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-10-18 | 6,000 | $2.36 | 6,000 | $2.36 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-10-20 | 10,000 | $2.68 | 10,000 | $2.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 47,086 | 2020-09-28 | No | 4 | M | Direct | |
| 129,219 | 2022-03-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 99,085 | Indirect | The Bonnie H. Anderson Living Trust |
Footnotes
- The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017.
- Represents weighted average sales price. Sale prices for the transactions range from $8.82 to $9.27. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- Actual sales price.
- The option becomes exercisable as to 25% of the shares on September 28, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- The option becomes exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
Billionaire Hedge Funds
